ES2053510T3 - Analogos de rebecamicina. - Google Patents

Analogos de rebecamicina.

Info

Publication number
ES2053510T3
ES2053510T3 ES87117167T ES87117167T ES2053510T3 ES 2053510 T3 ES2053510 T3 ES 2053510T3 ES 87117167 T ES87117167 T ES 87117167T ES 87117167 T ES87117167 T ES 87117167T ES 2053510 T3 ES2053510 T3 ES 2053510T3
Authority
ES
Spain
Prior art keywords
rebecamicine
analogs
intermediate compound
rebecamicina
rebecamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87117167T
Other languages
English (en)
Spanish (es)
Inventor
Takushi Kaneko
Henry S Wong
Jacob J Utzig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2053510T3 publication Critical patent/ES2053510T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
ES87117167T 1986-11-21 1987-11-20 Analogos de rebecamicina. Expired - Lifetime ES2053510T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (1)

Publication Number Publication Date
ES2053510T3 true ES2053510T3 (es) 1994-08-01

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87117167T Expired - Lifetime ES2053510T3 (es) 1986-11-21 1987-11-20 Analogos de rebecamicina.

Country Status (28)

Country Link
US (1) US4785085A (enExample)
EP (1) EP0269025B1 (enExample)
JP (1) JPS63198695A (enExample)
KR (1) KR910000897B1 (enExample)
CN (1) CN1019806B (enExample)
AT (1) ATE84539T1 (enExample)
AU (1) AU614068B2 (enExample)
CA (1) CA1287349C (enExample)
CS (1) CS265248B2 (enExample)
CY (1) CY1701A (enExample)
DE (1) DE3783577T2 (enExample)
DK (1) DK165986C (enExample)
EG (1) EG18409A (enExample)
ES (1) ES2053510T3 (enExample)
FI (1) FI86189C (enExample)
GR (1) GR3006776T3 (enExample)
HK (1) HK49093A (enExample)
HU (1) HU201773B (enExample)
IE (1) IE60595B1 (enExample)
IL (1) IL84515A (enExample)
MX (1) MX9202849A (enExample)
MY (1) MY102722A (enExample)
NO (1) NO167741C (enExample)
NZ (1) NZ222544A (enExample)
PT (1) PT86188B (enExample)
SG (1) SG25193G (enExample)
YU (1) YU46087B (enExample)
ZA (1) ZA878714B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
WO1991018003A1 (fr) * 1990-05-11 1991-11-28 Banyu Pharmaceutical Co., Ltd. Derive antitumoral de be-13793c
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
DE69323183T2 (de) * 1992-03-20 1999-05-27 The Wellcome Foundation Ltd., Greenford Weitere indolderivate mit antiviraler wirkung
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
NO308798B1 (no) * 1993-12-07 2000-10-30 Lilly Co Eli Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
ATE181049T1 (de) * 1993-12-07 1999-06-15 Lilly Co Eli Synthese von bisindolylmaleimiden
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
ATE456367T1 (de) * 1993-12-23 2010-02-15 Lilly Co Eli Proteinkinase c inhibitoren
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995034663A1 (en) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
DE69505470T2 (de) * 1994-08-04 1999-05-12 F. Hoffmann-La Roche Ag, Basel Pyrrolocarbazol
AU6836696A (en) * 1995-09-05 1997-03-27 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
BR9710648A (pt) * 1996-03-20 1999-08-17 Lilly Co Eli S¡ntese de indolilmaleimidas
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
RU2003131269A (ru) 2001-03-22 2005-05-10 Бристол-Маерс Сквибб Компани (Us) Производные индолопирролокарбазолов и сахаров, цитотоксические и селективные по отношению к топоизомеразе i
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
AU2004272457A1 (en) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. Novel indolopyrrolocarbazole derivative with antitumor activity
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Also Published As

Publication number Publication date
HU201773B (en) 1990-12-28
DK165986B (da) 1993-02-22
CN1019806B (zh) 1992-12-30
IE873152L (en) 1988-05-21
DE3783577D1 (de) 1993-02-25
DE3783577T2 (de) 1993-05-19
IL84515A (en) 1991-11-21
SG25193G (en) 1993-05-21
ATE84539T1 (de) 1993-01-15
CA1287349C (en) 1991-08-06
PT86188A (en) 1987-12-01
DK612987A (da) 1988-05-22
AU8114887A (en) 1988-05-26
MY102722A (en) 1992-09-30
FI875091A7 (fi) 1988-05-22
CY1701A (en) 1994-01-14
GR3006776T3 (enExample) 1993-06-30
EG18409A (en) 1993-02-28
NO167741B (no) 1991-08-26
DK612987D0 (da) 1987-11-20
IL84515A0 (en) 1988-04-29
NO874857L (no) 1988-05-24
FI86189B (fi) 1992-04-15
NO874857D0 (no) 1987-11-20
EP0269025A3 (en) 1990-08-29
EP0269025A2 (en) 1988-06-01
CN87107928A (zh) 1988-08-10
AU614068B2 (en) 1991-08-22
IE60595B1 (en) 1994-07-27
CS824987A2 (en) 1989-01-12
NZ222544A (en) 1990-11-27
PT86188B (pt) 1990-11-07
MX9202849A (es) 1992-06-30
FI86189C (fi) 1992-07-27
KR910000897B1 (ko) 1991-02-12
JPS63198695A (ja) 1988-08-17
FI875091A0 (fi) 1987-11-18
DK165986C (da) 1993-07-19
CS265248B2 (en) 1989-10-13
YU208687A (en) 1988-10-31
ZA878714B (enExample) 1988-05-20
KR880006246A (ko) 1988-07-22
HK49093A (en) 1993-05-27
YU46087B (sh) 1992-12-21
US4785085A (en) 1988-11-15
NO167741C (no) 1991-12-04
JPH05400B2 (enExample) 1993-01-05
EP0269025B1 (en) 1993-01-13
HUT45543A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
ES2053510T3 (es) Analogos de rebecamicina.
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
ES2140409T3 (es) Agente de contraste para rayos x.
ES2113867T3 (es) Imino-derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2137932T3 (es) Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
ES2081868T3 (es) Procedimiento para la preparacion de 2-(2',4'-dihidroxifenil)-4,6-diaril-s-triazinas.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
ES2053515T3 (es) Procedimiento para la preparacion de una sustancia especifica de un organo, marcada con tecnecio - 99 m.
ES2078749T3 (es) Procedimiento para preparar sertralina.
ES2167544T3 (es) Dioxidos de benzotiazina como antagonistas de la endotelina.
ES2179476T3 (es) Procedimiento para preparar derivados de pirazol.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2054746T3 (es) Aditivo para piensos estabilizado y procedimiento para su preparacion.
ES2166900T3 (es) Derivados de ara-c.
IT8520992A0 (it) Procedimento per la preparazione di composizioni plasto-elastomeriche poliolefiniche, mediante vulcanizzazione dinamica.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES2056789T3 (es) Inhibicion de la ruta de la 5-lipoxigenasa.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
IT1014081B (it) Procedimento per la preparazione di un estratto purificato di scor za di quillaja o legno di panama
AR241119A1 (es) "formulacion para flexibilizar polivinilcloruro, que comprende un ftalato como plastificante y una mezcla que comprende componentes de eter,eter-aalcohol y acetal seleccionada entre (a) el producto residual obtenido por hidrogeneracion y subsiguientes de
DE3871047D1 (de) Zusammensetzungen mit dichlortrifluorethan.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 269025

Country of ref document: ES